Marcus J Drake Selected Research

Marcus J Drake Research Topics

Disease

18	Lower Urinary Tract Symptoms 01/2022 - 11/2008
17	Overactive Urinary Bladder (Overactive Bladder) 01/2022 - 07/2008
12	Nocturia 01/2022 - 11/2017
6	Stress Urinary Incontinence 01/2021 - 04/2010
5	Urinary Incontinence 01/2021 - 04/2013
5	Urinary Retention 01/2021 - 11/2008
4	Polyuria 01/2022 - 11/2017
4	Hypertension (High Blood Pressure) 01/2022 - 10/2015
3	Inflammation (Inflammations) 01/2022 - 10/2013
2	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2022 - 01/2016
2	Fibrosis (Cirrhosis) 11/2018 - 01/2018
2	Multiple Sclerosis 08/2018 - 01/2018
2	Pelvic Pain 01/2018 - 04/2017
2	Pain (Aches) 01/2018 - 01/2014
1	Parasomnias (Parasomnia) 01/2022
1	Diabetes Insipidus 01/2022
1	Diabetes Mellitus 01/2022
1	Endocrine System Diseases (Endocrine Diseases) 01/2022
1	Heart Failure 01/2022
1	Hyperplasia 01/2022
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2022
1	Sleep Wake Disorders 01/2022
1	Thyroid Diseases (Thyroid Disease) 01/2022
1	Chronic Renal Insufficiency 01/2022
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2020
1	Neoplasms (Cancer) 11/2018
1	Spinal Cord Injuries (Spinal Cord Injury) 11/2018
1	Ataxia (Dyssynergia) 11/2018
1	Radiation Fibrosis Syndrome (Radiation Fibrosis) 11/2018
1	Cystitis 11/2018
1	Fatigue 01/2018
1	Tachycardia (Tachyarrhythmias) 05/2017
1	Headache (Headaches) 10/2015
1	Constipation 10/2015
1	Liver Failure 10/2015
1	Renal Insufficiency (Renal Failure) 10/2015
1	Prostatic Neoplasms (Prostate Cancer) 06/2015
1	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 08/2014
1	Infections 01/2014
1	Pathologic Processes 10/2013

Drug/Important Bio-Agent (IBA)

9	Solifenacin Succinate FDA Link 12/2017 - 12/2013
8	Muscarinic AntagonistsIBA 01/2021 - 10/2012
8	mirabegronIBA 12/2017 - 10/2015
4	Botulinum Toxins (Botulinum Toxin)IBA 01/2021 - 07/2008
4	Tamsulosin (Flomax)FDA LinkGeneric 01/2019 - 12/2013
3	SaltsIBA 01/2022 - 01/2022
3	Cholinergic Antagonists (Anticholinergics)IBA 11/2017 - 05/2017
3	TabletsIBA 01/2017 - 12/2013
2	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 01/2022 - 11/2017
2	CollagenIBA 01/2022 - 11/2018
2	Phosphodiesterase 5 InhibitorsIBA 01/2021 - 01/2016
2	Pharmaceutical PreparationsIBA 01/2020 - 11/2017
2	MelatoninIBA 08/2018 - 01/2018
2	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2018 - 04/2017
2	Type A Botulinum Toxins (Botox)FDA Link 11/2017 - 10/2017
2	Adrenergic Receptors (Adrenergic Receptor)IBA 05/2017 - 10/2015
1	Soluble Guanylyl CyclaseIBA 01/2022
1	AlbuminsIBA 01/2022
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2022
1	CreatinineIBA 01/2022
1	DiureticsIBA 01/2022
1	ElectrolytesIBA 01/2022
1	Heme (Haem)IBA 01/2022
1	LithiumIBA 01/2022
1	Urea (Carbamide)FDA LinkGeneric 01/2022
1	mesoglycanIBA 01/2021
1	Sildenafil Citrate (Viagra)FDA Link 01/2019
1	alfuzosin (UroXatral)FDA Link 01/2019
1	Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA 11/2018
1	LM11A-31IBA 11/2018
1	NitrogenIBA 11/2018
1	Therapeutic UsesIBA 11/2018
1	Oxygen (Dioxygen)IBA 11/2018
1	Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA 11/2018
1	RelaxinIBA 01/2018
1	Vitamin D FDA LinkGeneric 01/2018
1	EndostatinsIBA 01/2018
1	Hormones (Hormone)IBA 01/2018
1	AntioxidantsIBA 12/2016
1	Prostate-Specific Antigen (Semenogelase)IBA 06/2015
1	SmokeIBA 01/2015
1	AndrogensIBA 10/2013

Therapy/Procedure

20	Therapeutics 01/2022 - 10/2012
5	Conservative Treatment 01/2022 - 01/2015
5	Prostatectomy (Retropubic Prostatectomy) 01/2021 - 04/2010
3	Catheters 01/2021 - 01/2019
2	Artificial Urinary Sphincter 01/2019 - 04/2013
2	Bathroom Equipment 01/2018 - 12/2017
1	Polypharmacy 01/2022
1	Transurethral Resection of Prostate (TURP) 01/2021
1	Electrodes (Electrode) 01/2021
1	Suburethral Slings (Tension-Free Vaginal Tape) 01/2021
1	Aftercare (After-Treatment) 11/2020
1	Radiotherapy 11/2018
1	Cystectomy 11/2018
1	Injections 01/2018
1	Drug Tapering 10/2015
1	Autonomic Denervation 08/2014
1	Stents 01/2014
1	Drug Therapy (Chemotherapy) 10/2013